Becton, Dickinson and Company (BDX)
Automate Your Wheel Strategy on BDX
With Tiblio's Option Bot, you can configure your own wheel strategy including BDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BDX
- Rev/Share 76.1971
- Book/Share 88.5832
- PB 2.2823
- Debt/Equity 0.7555
- CurrentRatio 1.1133
- ROIC 0.0473
- MktCap 58158209142.0
- FreeCF/Share 9.3157
- PFCF 21.7821
- PE 34.5344
- Debt/Assets 0.3467
- DivYield 0.0206
- ROE 0.0663
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | BDX | RBC Capital Mkts | -- | Sector Perform | -- | $211 | Sept. 25, 2025 |
| Downgrade | BDX | Citigroup | Buy | Neutral | -- | $185 | May 22, 2025 |
| Downgrade | BDX | Raymond James | Outperform | Market Perform | -- | -- | May 2, 2025 |
| Downgrade | BDX | Goldman | Buy | Neutral | -- | $192 | May 2, 2025 |
| Downgrade | BDX | Piper Sandler | Overweight | Neutral | -- | $185 | May 2, 2025 |
| Downgrade | BDX | William Blair | Outperform | Market Perform | -- | -- | May 1, 2025 |
| Downgrade | BDX | BofA Securities | Buy | Neutral | -- | $190 | May 1, 2025 |
| Downgrade | BDX | Wells Fargo | Overweight | Equal Weight | -- | -- | May 1, 2025 |
| Upgrade | BDX | Citigroup | Neutral | Buy | $255 | $275 | Oct. 1, 2024 |
News
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
Published: January 07, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Read More
Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'
Published: January 07, 2026 by: Forbes
Sentiment: Neutral
Ignore the doom-and-gloom “predictions” about 2026. There are plenty of gains—and growing dividends—to be had for us this year.
Read More
Best Dividend Aristocrats For January 2026
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Read More
BD and Penn Institute Ink Collaboration to Advance Immunotherapy
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.
Read More
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
Published: December 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners
Published: December 17, 2025 by: Forbes
Sentiment: Positive
Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.
Read More
BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe
Published: December 16, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.
Read More
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
Read More
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
Published: November 17, 2025 by: PRNewsWire
Sentiment: Neutral
FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huffines and Jacqueline "Jacky" Wright to its board of directors, effective Dec. 1, 2025.
Read More
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
Read More
Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Becton, Dickinson and Company ( BDX ) Q4 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Adam Reiffe Thomas Polen - President, CEO & Chairman Christopher DelOrefice - Executive VP & CFO Conference Call Participants Travis Steed - BofA Securities, Research Division Patrick Wood - Morgan Stanley, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Hello, and welcome to BD's Fourth Quarter and Full Year Fiscal 2025 Earnings Call. At the request of …
Read More
3 Undervalued Dividend Kings to Buy on the Dip Right Now
Published: November 06, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend Kings are stocks that've had their dividend payouts raised for 50 consecutive years or more, such as Target (NYSE:TGT ), Becton Dickinson (NYSE:BDX ), and Hormel Foods (NYSE:HRL ).
Read More
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
Read More
Becton Dickinson (BDX) Reports Q4 Earnings: What Key Metrics Have to Say
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
3 Beaten-Down Dividend Aristocrats Ready to Rebound by 100%
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend Aristocrats are some of the best stocks to buy when they go on sale, as they're backed by companies on a solid footing.
Read More
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
Published: October 21, 2025 by: Zacks Investment Research
Sentiment: Positive
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
Read More
Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand
Published: October 20, 2025 by: Seeking Alpha
Sentiment: Positive
For my followup on medtech stock Becton, Dickinson and Company, I'm reaffirming my prior buy rating, agreeing with the Wall St consensus today. Becton, Dickinson's growing and globally diverse portfolio should continue to address the macro clinical demand in several areas. Despite unsteady cashflow growth trends, BDX continued to grow dividends steadily while also making major capital investments.
Read More
Fiduciary Management: A Few Holdings That We Find Compelling Over The Long Term
Published: October 16, 2025 by: Seeking Alpha
Sentiment: Positive
OneMain is a scale leader in nonprime personal lending. The macro backdrop has given us the opportunity to own OneMain at an attractive valuation. Becton, Dickinson's valuation is attractive given the company's defensive attributes and growth potential. Greggs' strong brand and differentiated business model have created loyal customers and long-term market share gains.
Read More
5 Dividend Aristocrats Are Perfect for Boomers Seeking Growth and Income
Published: October 15, 2025 by: 24/7 Wall Street
Sentiment: Positive
While reaching retirement age can be both a blessing and a curse, relying on the U.S.
Read More
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
Published: October 13, 2025 by: Zacks Investment Research
Sentiment: Negative
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
Read More
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Negative
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
Read More
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.
Published: October 03, 2025 by: PRNewsWire
Sentiment: Neutral
SUMTER, S.C. , Oct. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company's extensive U.S. manufacturing footprint.
Read More
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
Read More
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Published: September 23, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Fluorescence Cell Market Forecasts USD 6.37 Billion by 2034 at 7.29% CAGR
Published: September 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Fluorescence Cell Market (2024 - 2034) Report by Towards Healthcare, a sister firm of Precedence Research Fluorescence Cell Market (2024 - 2034) Report by Towards Healthcare, a sister firm of Precedence Research
Read More
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
About Becton, Dickinson and Company (BDX)
- IPO Date 1973-02-21
- Website https://www.bd.com
- Industry Medical - Instruments & Supplies
- CEO Thomas E. Polen Jr.
- Employees 70000